BACE1 and Alzheimer disease: Moreover, miR-29a and miR-29b-1 can downregulate BACE1 expression in human neuroblastoma cells, and these miRNAs were found to be downregulated in a cohort of AD patients with aberrantly high BACE1 levels [55].